Prkar1a in the regulation of insulin secretion.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4034137)

Published in Horm Metab Res on September 05, 2012

Authors

M A Hussain1, C Stratakis, L Kirschner

Author Affiliations

1: Department of Pediatrics, Medicine and Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. mhussai4@jhmi.edu

Articles cited by this

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet (2006) 15.76

The biology of incretin hormones. Cell Metab (2006) 8.92

Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet (2011) 3.50

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest (1984) 2.85

Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal (2010) 2.79

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab (2008) 2.40

The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci (2010) 2.22

Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab (2005) 2.04

The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab (2005) 1.72

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes (2002) 1.66

Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass. Diabetes (2010) 1.66

The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab (2002) 1.49

Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex. Nat Cell Biol (2001) 1.48

The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev (2001) 1.42

Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab (2011) 1.27

Characterization of the mouse pancreatic islet proteome and comparative analysis with other mouse tissues. J Proteome Res (2008) 1.23

Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology (2006) 1.20

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.17